Last Published 04.01.2026 Effective Date: 04.01.2026 This policy addresses arterial compliance testing using waveform analysis, carotid intima-media thickness (CIMT) measurement, advanced lipoprotein analysis, endothelial function assessment, and tests for lipoprotein-associated phospholipase A2 (Lp-PLA2) enzyme, other human A2 phospholipases, long-chain omega-3 fatty acids, and multi-protein biomarkers
I can fully understand why people will want to try this but Im concerned about what might happen if they do
Long-term data (beyond 2 years) remain limited, so open communication with your provider is critical
Flagman Force Rank Feeder + Flagman Legend Feeder 5500 FD + + ,
Better glucose and lipid dynamics Even in people without diabetes, GLP-1 medications can improve post-meal metabolic spikes